Norman E. Clarke

424 total citations
10 papers, 252 citations indexed

About

Norman E. Clarke is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Norman E. Clarke has authored 10 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Norman E. Clarke's work include Toxin Mechanisms and Immunotoxins (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Norman E. Clarke is often cited by papers focused on Toxin Mechanisms and Immunotoxins (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Norman E. Clarke collaborates with scholars based in United States. Norman E. Clarke's co-authors include Robert E. Mosher and Callisia N. Clarke and has published in prestigious journals such as Circulation, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Norman E. Clarke

9 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman E. Clarke United States 8 62 48 40 39 30 10 252
J. Roderick Kitchell United States 11 78 1.3× 40 0.8× 32 0.8× 62 1.6× 29 1.0× 18 263
C.T. Bello United States 6 107 1.7× 34 0.7× 21 0.5× 30 0.8× 8 0.3× 11 313
J. Colley United Kingdom 9 85 1.4× 20 0.4× 104 2.6× 107 2.7× 22 0.7× 15 384
Gurdarshan S. Thind United States 12 154 2.5× 88 1.8× 22 0.6× 55 1.4× 11 0.4× 26 404
O L Ramos Brazil 9 59 1.0× 62 1.3× 26 0.7× 42 1.1× 5 0.2× 26 341
J. R. H. Brentjens Netherlands 5 45 0.7× 17 0.4× 65 1.6× 20 0.5× 8 0.3× 7 354
A.I. Macdougall United Kingdom 12 42 0.7× 124 2.6× 66 1.6× 63 1.6× 5 0.2× 20 512
Brown Mj United Kingdom 6 72 1.2× 116 2.4× 39 1.0× 68 1.7× 6 0.2× 15 382
Thomas J. Bixler United States 10 97 1.6× 113 2.4× 68 1.7× 87 2.2× 27 0.9× 19 489
Byron B. Clark United States 10 35 0.6× 20 0.4× 10 0.3× 13 0.3× 4 0.1× 18 249

Countries citing papers authored by Norman E. Clarke

Since Specialization
Citations

This map shows the geographic impact of Norman E. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman E. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman E. Clarke more than expected).

Fields of papers citing papers by Norman E. Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman E. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman E. Clarke. The network helps show where Norman E. Clarke may publish in the future.

Co-authorship network of co-authors of Norman E. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Norman E. Clarke. A scholar is included among the top collaborators of Norman E. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman E. Clarke. Norman E. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Clarke, Norman E. & Robert E. Mosher. (1960). TREATMENT OF OCCLUSIVE VASCULAR DISEASE WITH DISODIUM ETHYLENE DIAMINE TETRAACETIC ACID (EDTA). The American Journal of the Medical Sciences. 239(6). 732–744. 21 indexed citations
2.
Clarke, Norman E.. (1960). Atherosclerosis, occlusive vascular disease and EDTA. The American Journal of Cardiology. 6(2). 233–236. 19 indexed citations
3.
Clarke, Norman E., et al.. (1958). PHENOLIC COMPOUNDS IN CHEMOTHERAPY OF RHEUMATIC FEVER. The American Journal of the Medical Sciences. 235(1). 7–22. 25 indexed citations
4.
Clarke, Norman E., et al.. (1956). TREATMENT OF ANGINA PECTORIS WITH DISODIUM ETHYLENE DIAMINE TETRAACETIC ACID. The American Journal of the Medical Sciences. 232(6). 654–666. 65 indexed citations
5.
Clarke, Norman E., Callisia N. Clarke, & Robert E. Mosher. (1956). Chemotherapy of rheumatic fever.. PubMed. 55(5). 517–9. 1 indexed citations
6.
Clarke, Norman E., et al.. (1955). THE “IN VIVO” DISSOLUTION OF METASTATIC CALCIUM AN APPROACH TO ATHEROSCLEROSIS. The American Journal of the Medical Sciences. 229(2). 142–149. 53 indexed citations
7.
Clarke, Norman E. & Robert E. Mosher. (1953). Phenolic Compounds in the Treatment of Rheumatic Fever. Circulation. 7(3). 337–344. 7 indexed citations
8.
Clarke, Norman E., et al.. (1953). Phenolic Compounds in the Treatment of Rheumatic Fever. Circulation. 7(2). 247–257. 19 indexed citations
9.
Clarke, Norman E. & Robert E. Mosher. (1952). The Water and Electrolyte Content of the Human Heart in Congestive Heart Failure with and without Digitalization. Circulation. 5(6). 907–914. 39 indexed citations
10.
Clarke, Norman E., et al.. (1952). Coarctation of the aorta. American Heart Journal. 43(1). 108–110. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026